• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Latest News about Novo Nordisk A/S

    Recent news which mentions Novo Nordisk A/S

    < Previous 1 2 3 4 5 6 7 8 Next >
    Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says
    Tags LILLY DRN Health & Science Companies
    From CNBC.com News
    Hiccups in ETFs tracking MicroStrategy occurring as bull market fuels trading boom in single-stock funds
    Tags NVIDIA Corp Microstrategy Inc Investment strategy
    From CNBC.com News
    Eli Lilly's Zepbound causes greater weight loss than Novo Nordisk's Wegovy in head-to-head trial
    Tags Health care industry Business News Biotech and Pharmaceuticals
    From CNBC.com News
    5 things to know before the stock market opens Tuesday
    Tags Investing Business Nordstrom Inc
    From CNBC.com News
    Amgen says obesity drug caused up to 20% weight loss after a year, with no plateau
    Tags Health care industry Business News Biotech and Pharmaceuticals
    From CNBC.com News
    Amgen stock falls as analysts mull over weight loss drug’s bone density data
    Tags Novo Nordisk A/S US: News Business
    From CNBC.com News
    Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
    Tags Viking Therapeutics Inc Health care industry Biotech and Pharmaceuticals
    From CNBC.com News
    Healthy Returns: Wegovy may reduce knee pain in patients with a type of arthritis and obesity
    Tags Biotech and Pharmaceuticals Novo Nordisk A/S UnitedHealth Group Inc
    From CNBC.com News
    Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says
    Tags Pharmaceuticals Breaking news Biotechnology
    From CNBC.com News
    Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says
    Tags Novo Nordisk A/S Obesity Biotechnology
    From CNBC.com News
    Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
    Tickers HIMS LLY NEWS NVO
    Tags Politics News Shivdeep Dhaliwal
    From Benzinga
    Healthy Returns: Weight loss, diabetes drugs may reduce alcohol and opioid use
    Tags Novo Nordisk A/S Microsoft Corp Biotech and Pharmaceuticals
    From CNBC.com News
    Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
    Tags Pharmaceuticals Novo Nordisk A/S Biotechnology
    From CNBC.com News
    Healthy Returns: Covering weight loss drugs could cost Medicare $35 billion through 2034
    Tags LILLY DRN Health care industry Health & Science
    From CNBC.com News
    Cramer's Lightning Round: Uranium Energy is 'the real deal'
    Tags Market Outlook Stock Picks Business News
    From CNBC.com News
    Wegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO says
    Tags LILLY DRN Zealand Pharma A/S Pharmaceuticals
    From CNBC.com News
    Ozempic underworld: Inside the black market of obesity drugs
    Tags CNBC Investigations Health & Science Business
    From CNBC.com News
    CNBC Daily Open: October’s gravity bringing stocks down
    Tickers JOBS OIL
    Tags Oil Markets Market Outlook
    From CNBC.com News
    Friday's big stock stories: What’s likely to move the market in the next trading session
    Tags Tencent Holdings Ltd Ford Motor Co Tesla Inc
    From CNBC.com News
    Port strike fallout: Blockbuster weight-loss drug supply from Wegovy to Ozempic, Mounjaro, Zepbound caught up in East Coast trade shutdown
    Tags Shipping Transportation and shipping Drugs
    From CNBC.com News
    East and Gulf Coast ports strike, with ILA longshoremen walking off job, stranding billions in trade
    Tags U/S/ Economy Economy Novo Nordisk A/S
    From CNBC.com News
    Novo Nordisk's diabetes drug Ozempic may lower the risk of opioid overdoses, study says
    Tags Biotechnology Business US: News
    From CNBC.com News
    5 things to know before the stock market opens Wednesday
    Tags Technology Business News 5 Things to Know
    From CNBC.com News
    Healthy Returns: Weight loss drug Wegovy could face Medicare price negotiations next
    Tags Social issues Novo Nordisk A/S GSK plc
    From CNBC.com News
    Novo Nordisk CEO to testify at Senate hearing over high weight loss drug prices
    Tags Health care industry Business News Biotech and Pharmaceuticals
    From CNBC.com News
    Tuesday's big stock stories: What's likely to move the market in the next trading session
    Tags Pultegroup Inc stocks Vistra Corp
    From CNBC.com News
    Bernie Sanders Questions Why Your Monthly Ozempic Prescription Costs More Than A Luxury Handbag When It Can Be Sold For Less Than $100
    Tickers NEWS NVO
    Tags Shivdeep Dhaliwal News Diabetes
    From Benzinga
    FTC sues drug middlemen for allegedly inflating insulin prices
    Tags UnitedHealth Group Inc Health care industry Business News
    From CNBC.com News
    Novartis not joining the 'frenzy' of weight loss drugs, CEO says
    Tags Novo Nordisk A/S Biotech and Pharmaceuticals Roche Holding AG
    From CNBC.com News
    Healthy Returns: How competitive can Roche be in the weight loss drug market?
    Tags Biotech and Pharmaceuticals Roche Holding AG Novo Nordisk A/S
    From CNBC.com News
    < Previous 1 2 3 4 5 6 7 8 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.